MYSPX
Price
$63.93
Change
+$0.66 (+1.04%)
Updated
Jun 6 closing price
Net Assets
1.59B
VITSX
Price
$143.69
Change
+$1.51 (+1.06%)
Updated
Jun 6 closing price
Net Assets
1.82T
Interact to see
Advertisement

MYSPX vs VITSX

Header iconMYSPX vs VITSX Comparison
Open Charts MYSPX vs VITSXBanner chart's image
NYLI S&P 500 Index Investor Class
Price$63.93
Change+$0.66 (+1.04%)
VolumeN/A
Net Assets1.59B
Vanguard Total Stock Market Idx I
Price$143.69
Change+$1.51 (+1.06%)
VolumeN/A
Net Assets1.82T
MYSPX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MYSPX vs. VITSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MYSPX is a StrongBuy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.82T vs. MYSPX (1.59B). VITSX pays higher dividends than MYSPX: VITSX (1.29) vs MYSPX (0.66). MYSPX was incepted earlier than VITSX: MYSPX (17 years) vs VITSX (28 years). MYSPX (0.80) is less costly to investors than VITSX (0.03). MYSPX (2.00) and VITSX (2.00) have comparable annual turnover. MYSPX has a lower initial minimum investment than VITSX: MYSPX (1000) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 10.97 vs. MYSPX (8.36). VITSX return over 5 years is better than : 80.96 vs. MYSPX (48.58).
MYSPXVITSXMYSPX / VITSX
Total Expense Ratio0.800.032,667%
Annual Report Gross Expense Ratio0.800.032,667%
Fund Existence17 years28 years-
Gain YTD2.3040.833277%
Front Load1%N/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.59B1.82T0%
Annual Yield % from dividends0.661.2951%
Returns for 1 year8.3610.9776%
Returns for 3 years26.5540.3566%
Returns for 5 years48.5880.9660%
Returns for 10 years39.96180.4922%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRMR2.680.22
+8.94%
Larimar Therapeutics
CATX3.320.20
+6.41%
Perspective Therapeutics
J127.672.67
+2.14%
Jacobs Solutions
HL6.27-0.18
-2.79%
Hecla Mining Company
CYCC0.37-0.24
-38.84%
Cyclacel Pharmaceuticals Inc.